News Focus
News Focus
Followers 92
Posts 7487
Boards Moderated 1
Alias Born 09/18/2009

Re: SorcererGuru44 post# 42827

Monday, 07/01/2024 1:37:01 PM

Monday, July 01, 2024 1:37:01 PM

Post# of 44330
I previously discussed the market's response to our LIVE- AIR topline data (TLD) which allowed me to sell shares for an average price in the $28 range. To now reach a Milestone Event, as the court deems is likely, based on amending the Asset Purchase Agreement, would require receipt of a BLA or regulatory approval, and that would have a greater share price reaction than the news of our TLD.

Even non-regulatory news, such as a merger leading to a business relationship with Sanofi/Novavax, would cause a spike in the share price. Given that I think Humanigen has control of about 90% of the shares they have issued, here again, more than enough profit could be generated by the company selling shares into that news, to pay off all financial obligations.

I am convinced that the positive events I just outlined will transpire. It doesn't make sense that the company would deal us out of the reward following good news. Payment in full to creditors would amount to a pittance of what would be gained in a short squeeze.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today